Consumer analysis · from the 250-topic plan
The 90-day fill question: multi-month supplies versus the clock printed on your vial
Brand pens carry factory expiration dates measured in months-to-years; compounded vials carry beyond-use dates (BUDs) — pharmacy-assigned under USP sterile-compounding standards, commonly ranging from days to a couple of months refrigerated depending on the pharmacy's testing tier. That single difference decides the 90-day-supply question: a three-month shipment only makes sense if every vial's use window fits inside its printed BUD, and only for patients whose dose won't move mid-supply. Stable maintenance patients can bank real savings and shipping resilience; titrating patients mostly bank waste. Here's the clock, the dose-change trap, and the four questions that settle any multi-month offer.
BUDs versus expiration dates — different clocks entirely
A brand product's expiration date emerges from formal stability programs on the exact commercial formulation. A compounded sterile preparation instead gets a beyond-use date assigned by the pharmacy under USP's sterile-compounding framework, where allowable windows scale with the rigor of the pharmacy's environment and testing — from short default windows without sterility testing to substantially longer refrigerated windows for preparations that earn them through testing tiers. Two consequences for shoppers: BUDs vary legitimately between pharmacies (a longer BUD can signal a higher-testing operation, not corner-cutting — the COA guide pairs with this page), and your vial's label is the only clock that governs: “90-day supply” is a shipping quantity, not a stability promise.
The fit test
The arithmetic is one sentence: for each vial in the shipment, days-until-you'll-finish-it must fit inside its BUD from your receipt date. A three-month order shipped as three vials, each opened in sequence well inside its window, can fit cleanly; the same order as fewer, larger vials — or with BUDs already partially consumed by pharmacy-to-porch time — can strand medicine past its clock. Add the cold-chain dimension (three months of product on one summer porch afternoon is triple exposure) and the fit test earns its place before any bulk discount does.
The titration trap
The quieter failure isn't chemistry; it's the ladder. A patient mid-titration who orders 90 days at the current concentration is betting the dose stands still — and titration's whole premise is that it won't. A step up mid-supply means re-running vial math on old concentration (workable but error-inviting) or replacing stock (the discount, refunded in waste); a clinician-ordered hold or step-down strands it in the other direction. The clean rule: multi-month fills are a maintenance-phase instrument — and a program pushing 90-day commitments on week-four patients is optimizing its cash flow against your ladder.
When 90 days genuinely wins
For a patient stable at maintenance dose for a couple of cycles, with confirmed per-vial BUD fit and fridge space: real advantages accrue — per-month discounts where offered, one shipping-risk event instead of three, insulation from month-to-month price mischief, and travel convenience. Priced honestly against the audited flat benchmarks ($139/$119 monthly, all-in, no bulk gymnastics required), a 90-day discount has a bar to clear — but for stable patients whose program prices bulk fairly and answers the questions below in writing, clearing it is possible. This is that rare pricing structure this site's verdict on is genuinely “it depends — here's the checklist,” not “it's a trap.”
The four questions, in writing
“What is the BUD printed on each vial you'll ship, from what date, and does my three-month schedule fit inside each?” “If my clinician changes my dose mid-supply, what happens — exchange, credit, or my loss?” “How is a 90-day shipment packed for heat, and what's the replacement policy per the cold-chain standard?” “What exactly is the per-month price versus monthly billing — all fees in?” Four clean answers make a multi-month fill a rational instrument; any refusal converts the discount back into a bet. The monthly benchmark to beat ↗
FAQ
How long do compounded GLP-1 vials last?
Per the beyond-use date printed on each vial — pharmacy-assigned under USP sterile-compounding standards and commonly days to a couple of months refrigerated depending on testing tier. The label's BUD, not the shipping quantity, is the clock.
Is a 90-day compounded supply safe to order?
When every vial's use schedule fits inside its BUD from receipt, cold-chain packing is specified, and your dose is stable at maintenance — yes; mid-titration, it mostly buys waste.
Why do BUDs differ between pharmacies?
USP's framework scales allowable windows with environmental and testing rigor — longer refrigerated BUDs can reflect higher-testing operations, verified through the COA and licensure chain.
What if my dose changes mid-supply?
Get the program's written policy first — exchange, credit, or forfeiture — because that clause, not the discount, is the multi-month offer's real price.
Sources
- USP sterile-compounding framework — beyond-use dating structure and testing tiers.
- Brand prescribing information — storage and expiration for contrast.
- Cold-chain and vial-math companion analyses on this site; audited monthly benchmarks — the open dataset.